Dothideales

The type specimens or representative specimens of the potentially dothidealean genera Bagnisiella, Botryochora, Coccostromella, Columnosphaeria, Delphinella, Dictyodothis, Discosphaerina, Dothidea, Dothiora, Endodothiora, Jaffuela, Mycoporis, Omphalospora, Pachysacca, Plowrightia, Saccothecium, Stylodothis, Sydowia and Yoshinagaia were examined while, fresh specimens of Aureobasidium pullulans, Dothidea insculpta, Plowrightia ribesia and Saccothecium sepincola were made from Italy and Thailand. An introduction and the history of these genera, their family placement, morphology, and molecular phylogeny are provided. Morphology plus GenBank data are used to provide a systematic treatment of Dothideales. Phylogenetic analysis of LSU, SSU and ITS gene regions was carried out and in the resulting phylogenetic tree the taxa cluster in two clades with high bootstrap support. Clade A comprises Dothideaceae, the family type of Dothideales. The family Dothioraceae is not recognized as a distinct family and is synonymized under Dothideaceae. Neocylindroseptoria is introduced to accommodate Cylindroseptoria pistaciae as it forms a well-supported distinct clade in Dothideaceae. Clade B comprises Aureobasidium, Kabatiella, Pseudoseptoria, Saccothecium and Selenophoma species and Columnosphaeria fagi, for which we propose a new family, Aureobasidiaceae. The recently introduced Sydowia eucalypti also clustered within Clade B and therefore based on morphology and molecular phylogeny a new genus Pseudosydowia is introduced for Sydowia eucalypti. Celosporium laricicola is separated in a distinct clade, and therefore it is placed in Dothideales, genera, incertae sedis. The genera Bagnisiella, Botryochora, Coccostromella, Jaffuela, Lucidascocarpa, Mycoporis, Omphalospora, Pachysacca and Yoshinagaia are excluded from Dothideales and their placements are discussed.     

The sooty moulds

Sooty moulds are a remarkable, but poorly understood group of fungi. They coat fruits and leaves superficially with black mycelia, which reduces photosynthesis rates of host plants. Few researchers have, however, tried to quantify their economic importance. Sooty moulds have been well-studied at the morphological level, but they are poorly represented in a natural classification based on phylogeny. Representatives are presently known in Antennulariellaceae, Capnodiaceae, Chaetothyriaceae, Coccodiniaceae, Euantennariaceae, Metacapnodiaceae and Trichomeriaceae and several miscellaneous genera. However, molecular data is available for only five families. Most sooty mould colonies comprise numerous species and thus it is hard to confirm relationships between genera or sexual and asexual states. Future studies need to obtain single spore isolates of species to test their phylogenetic affinities and linkages between morphs. Next generation sequencing has shown sooty mould colonies to contain many more fungal species than expected, but it is not clear which species are dominant or active in the communities. They are more common in tropical, subtropical and warm temperate regions and thus their prevalence in temperate regions is likely to increase with global warming. Sooty moulds are rarely parasitized by fungicolous taxa and these may have biocontrol potential. They apparently grow in extreme environments and may be xerophilic. This needs testing as xerophilic taxa may be of interest for industrial applications. Sooty moulds grow on sugars and appear to out-compete typical “weed” fungi and bacteria. They may produce antibiotics for this purpose and their biochemical potential for obtaining novel bioactive compounds for medical application is underexplored.     

Hybrid approach to postmyocardial infarction ventricular septal defect repair

Postinfarction ventricular septal rupture is a rare and devastating complication of myocardial infarction. Despite attempts at acute surgical and percutaneous defect closure, morbidity and mortality remain high. Herein, we describe a hybrid surgical and catheter-based approach to defect closure in a 63-year-old woman with postinfarction ventricular septal rupture and cardiogenic shock.     

Inhibition of day-12 spleen colony-forming units by a monoclonal antibody to the murine macrophage/monocyte colony-stimulating factor receptor

Primitive hematopoietic stem cells differentiate into committed progenitors that are thought to selectively express hematopoietic growth factor receptor(s), thereby acquiring hematopoietic growth factor responsiveness. To assess whether hematopoietic stem cells express hematopoietic growth factor receptors, the progenitor activity of bone marrow (BM) fractions, isolated by expression of receptors for macrophage/monocyte colony-stimulating factor (M-CSF), were examined. Recovery of day-12 spleen colony-forming units (CFU-S) is diminished in both M-CSF receptor-positive (M-CSFR+) and M-CSFR- fractions, indicating antibody inhibition of day-12 CFU-S. Incubation of BM cells with antibody without fractionation inhibits 50% to 60% of day-12 CFU- S. This inhibition is specific (control antibodies have no effect) and reversible by removal of bound antibody at low pH. Incubating BM cells with control or antireceptor antibody does not affect day-8 CFU-S, which are predominantly erythroid. Treating sublethally irradiated mice with antibody inhibits endogenous day-12 CFU-S. These results indicate that some early progenitors express M-CSFRs, and blocking M-CSFRs inhibits the ability of these progenitors to form colonies, possibly because of inactivation caused by prolonged receptor blockade.     

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811

The goal of this phase II multicenter clinical trial was to evaluate a new intensive chemotherapy program for adults with untreated acute lymphoblastic leukemia (ALL) and to examine prospectively the impact of clinical and biologic characteristics on the outcome. One hundred ninety-seven eligible and evaluable patients (16 to 80 years of age; median, 32 years of age) received cyclophosphamide, daunorubicin, vincristine, prednisone, and L-asparaginase; 167 patients (85%) achieved a complete remission (CR), 13 (7%) had refractory disease, and 17 (9%) died during induction. A higher CR rate was observed in younger patients (94% for those < 30 years old, 85% for those 30 to 59 years old, and 39% for those > or = 60 years old, P < .001) and in those who had a mediastinal mass (100%) or blasts with a T-cell immunophenotype. Eighty percent of B-lineage and 97% of T-cell ALL patients achieved a CR (P = .01). The coexpression of myeloid antigens did not affect the response rate or duration. Seventy percent of those with cytogenetic or molecular evidence of the Philadelphia (Ph) chromosome and 84% of those without such evidence achieved a CR (P = .11). Patients in remission received multiagent consolidation treatment, central nervous system prophylaxis, late intensification, and maintenance chemotherapy for a total of 24 months. After a median follow-up time of 43 months, the median survival for all 197 patients is 36 months; the median remission duration for the 167 CR patients is 29 months. Favorable pretreatment characteristics relative to remission duration or survival are younger age, the presence of a mediastinal mass or lymphadenopathy, a white blood cell count (WBC) less than 30,000/microL, L1 morphology, T or TMy immunophenotype, and the absence of the Ph chromosome. The estimates of the proportion surviving at 3 years are 69% for patients less than 30 years old, 39% for those 30 to 59 years old, 89% for those who had a mediastinal mass, 59% with WBC less than 30,000/microL, 63% with L1 morphology, 69% for T or TMy antigen expression, and 62% for those who lack the Ph chromosome. Fifteen patients (8%) had no unfavorable prognostic factors and have an estimated probability of survival at 5 years of 100% (95% confidence interval, 77% to 100%). This intensive chemotherapy regimen produces a high remission rate and a high proportion of durable remissions in adults with ALL.     

Rapid prenatal diagnosis of beta thalassemia using DNA amplification and nonradioactive probes

We used in vitro DNA amplification by the polymerase chain reaction and nonradioactive probes for prenatal diagnosis of beta thalassemia in Chinese from the Guangdong province. Exact molecular diagnoses were made in all 20 fetuses studied over a 6-month period. We conclude that this method of prenatal diagnosis for beta thalassemia is a viable approach in many parts of the world where this disease is common.     

Coincidental diagnosis of tuberculous lymphadenitis: a case report

The aim of this case report was to present a case of multiple calcified tuberculous lymph nodes found on a panoramic radiograph coincidently diagnosed in an endodontic clinic. A detailed discussion on the differential diagnosis of similar such calcification found in the same region is also presented. A 14‐year‐old girl was referred to our department with the complaint of painless swelling in the left side of the lower jaw. Clinical and radiographical examinations were performed, leading to the initial diagnosis of chronic periapical abscess. The patient's medical history was re‐evaluated. Advanced imaging and excisional biopsy were performed in order to confirm the final diagnosis. Regarding the presenting signs and symptoms of bilateral carious mandibular molars, a periapical inflammatory process was considered in the provisional diagnosis. A thorough examination and investigations were suggestive of cervical tuberculous lymphadenitis (scrofula), and the patient underwent excision of the same. The clinician should consider the possibility of chronic granulomatous inflammatory lesions in the differential diagnosis of radiopaque lesions.